Elhidsi M

ORCID: 0000-0002-5005-044X · 1 paper in corpus

2022

Effectiveness and safety profile of mesenchymal stem cell secretome as a treatment for severe cases of COVID-19: a randomized controlled trial.

F1000Research ·doi:10.12688/f1000research.75580.2

Background: : Patients with severe COVID-19 had a higher increase in pro-inflammatory and anti-inflammatory cytokines than patients with moderate COVID-19. Excessive release of cytokine and chemokines can lead to multi-organ failure, increa…